# FDA Inspection 1002871 - NAMSA - February 16, 2017

Source: https://www.keypedia.com/records/fda_inspections/namsa/77838969-bec2-4ad3-af0d-e4f970b5be87
Source feed: FDA_Inspections

> FDA Inspection 1002871 for NAMSA on February 16, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1002871
- Company Name: NAMSA
- Inspection Date: 2017-02-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Devices
- Office Name: Center for Devices and Radiological Health

## Related Documents

- [FDA Inspection 1197992 - 2023-02-08](https://www.keypedia.com/records/fda_inspections/namsa/7f06b5fb-e377-403f-83fe-aa2e6df39f23)
- [FDA Inspection 1052433 - 2018-05-18](https://www.keypedia.com/records/fda_inspections/namsa/2042a26e-1fb3-47f8-9d5f-0db77501eea7)
- [FDA Inspection 819156 - 2013-02-04](https://www.keypedia.com/records/fda_inspections/namsa/6fc21266-c02e-4542-821a-7d8028eca13b)
- [FDA Inspection 676437 - 2010-09-03](https://www.keypedia.com/records/fda_inspections/namsa/edbe69df-7b84-44ef-b60e-8a2feb519632)

Company: https://www.keypedia.com/companies/namsa/f682195b-ca54-4a02-b106-71b74e647b2e

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7
